Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Objective 1: To compare the effects of etoricoxib 90 mg once daily to naproxen 1000 mg in the treatment of ankylosing spondylitis as measured by Spinal Pain Intensity (0- to 100-mm VAS, Question 2 of Bath Ankylosing Spondylitis Disease Activity Index, BASDAI) over 6-weeks of treatment in Part I. Objective 2: To compare the effects of etoricoxib 60 mg once daily to naproxen 1000 mg in the treatment of ankylosing spondylitis as measured by Spinal Pain Intensity (0- to 100-mm VAS, Question 2 of Bath Ankylosing Spondylitis Disease Activity Index, BASDAI) over 6-weeks of treatment in Part I. Objective 3: To evaluate the overall tolerability of etoricoxib (90 mg and 60 mg once daily) in ankylosing spondylitis patients.
Critère d'inclusion
- Ankylosing spondylitis (AS)